Equities Analysts Increase Earnings Estimates for Amgen, Inc. (NASDAQ:AMGN)
Amgen, Inc. (NASDAQ:AMGN) – Research analysts at Oppenheimer lifted their Q4 2019 earnings per share (EPS) estimates for Amgen in a report released on Sunday, December 1st, Zacks Investment Research reports. Oppenheimer analyst J. Olson now forecasts that the medical research company will earn $3.44 per share for the quarter, up from their previous estimate of $3.10. Oppenheimer has a “Buy” rating and a $240.00 price target on the stock. Oppenheimer also issued estimates for Amgen’s FY2020 earnings at $16.71 EPS.